Patrick J. Loehrer

26.2k total citations · 6 hit papers
362 papers, 18.6k citations indexed

About

Patrick J. Loehrer is a scholar working on Oncology, Surgery and Neurology. According to data from OpenAlex, Patrick J. Loehrer has authored 362 papers receiving a total of 18.6k indexed citations (citations by other indexed papers that have themselves been cited), including 165 papers in Oncology, 124 papers in Surgery and 101 papers in Neurology. Recurrent topics in Patrick J. Loehrer's work include Myasthenia Gravis and Thymoma (72 papers), Testicular diseases and treatments (58 papers) and Neuroblastoma Research and Treatments (42 papers). Patrick J. Loehrer is often cited by papers focused on Myasthenia Gravis and Thymoma (72 papers), Testicular diseases and treatments (58 papers) and Neuroblastoma Research and Treatments (42 papers). Patrick J. Loehrer collaborates with scholars based in United States, Kenya and Canada. Patrick J. Loehrer's co-authors include Lawrence H. Einhorn, Stephen D. Williams, Robert J. Mayer, Justin Kopit, Leonard B. Saltz, Neal J. Meropol, Michael N. Needle, Craig R. Nichols, F. Anthony Greco and Robert Birch and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Patrick J. Loehrer

345 papers receiving 18.1k citations

Hit Papers

Phase II Trial of Cetuxim... 1984 2026 1998 2012 2004 1984 1987 1992 1998 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor Receptor
    2004 1.4k citations Patrick J. Loehrer et al. Journal of Clinical Oncology profile →
  2. Cisplatin
    1984 861 citations Patrick J. Loehrer et al. profile →
  3. Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or Etoposide
    1987 825 citations Stephen D. Williams, Lawrence H. Einhorn et al. profile →
  4. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.
    1992 752 citations Patrick J. Loehrer, Lawrence H. Einhorn et al. Journal of Clinical Oncology profile →
  5. Bilateral Orchiectomy with or without Flutamide for Metastatic Prostate Cancer
    1998 685 citations Patrick J. Loehrer, George Wilding et al. profile →
  6. Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial
    2011 604 citations Patrick J. Loehrer, Yang Feng et al. Journal of Clinical Oncology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Patrick J. Loehrer 7.8k 6.9k 4.8k 4.6k 3.3k 362 18.6k
Lawrence H. Einhorn 16.7k 2.1× 7.2k 1.0× 7.2k 1.5× 5.1k 1.1× 6.1k 1.8× 548 27.3k
Mark Krailo 4.1k 0.5× 5.7k 0.8× 6.8k 1.4× 3.5k 0.8× 4.5k 1.4× 392 18.7k
Patrick Schöffski 3.2k 0.4× 9.6k 1.4× 9.5k 2.0× 1.5k 0.3× 4.8k 1.5× 510 19.4k
Herbert Chen 7.8k 1.0× 4.2k 0.6× 2.1k 0.4× 1.6k 0.4× 3.7k 1.1× 570 20.2k
Hans‐Joachim Schmoll 7.5k 1.0× 9.8k 1.4× 4.6k 1.0× 1.6k 0.4× 3.7k 1.1× 541 19.2k
Ian Judson 5.0k 0.6× 10.8k 1.6× 16.5k 3.4× 2.1k 0.4× 6.0k 1.8× 403 28.0k
Carsten Bokemeyer 11.6k 1.5× 14.2k 2.1× 9.8k 2.0× 2.7k 0.6× 9.5k 2.9× 957 36.1k
Ronald de Wit 9.2k 1.2× 10.2k 1.5× 13.4k 2.8× 763 0.2× 4.5k 1.4× 373 26.4k
Andrew K. Stewart 5.8k 0.7× 7.6k 1.1× 4.6k 0.9× 530 0.1× 1.9k 0.6× 166 15.1k
Filippo de Braud 5.6k 0.7× 17.9k 2.6× 8.8k 1.8× 1.1k 0.2× 5.7k 1.7× 754 26.7k

Countries citing papers authored by Patrick J. Loehrer

Since Specialization
Citations

This map shows the geographic impact of Patrick J. Loehrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick J. Loehrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick J. Loehrer more than expected).

Fields of papers citing papers by Patrick J. Loehrer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick J. Loehrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick J. Loehrer. The network helps show where Patrick J. Loehrer may publish in the future.

Co-authorship network of co-authors of Patrick J. Loehrer

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick J. Loehrer. A scholar is included among the top collaborators of Patrick J. Loehrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick J. Loehrer. Patrick J. Loehrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morgan, Jennifer, et al.. (2025). Global Equity in Clinical Trials: A Pragmatic Approach. JCO Global Oncology. 11(11). e2400557–e2400557. 1 indexed citations
2.
Busakhala, Naftali, et al.. (2025). Characteristics and Associated Survival of Patients Diagnosed With Non–Small Cell Lung Cancer in a Designated Lung Cancer Program in Western Kenya. JCO Global Oncology. 11(11). e2400212–e2400212. 1 indexed citations
3.
Bourlon, María T., Ami S. Bhatt, Gilberto Lopes, et al.. (2024). Envisioning Academic Global Oncologists: Proposed Competencies for Global Oncology Training From ASCO. JCO Global Oncology. 10(10). e2300157–e2300157. 1 indexed citations
4.
Mesa, Hector, et al.. (2023). Enteric adenocarcinoma of the Thymus. American Journal of Clinical Pathology. 160(Supplement_1). S56–S57.
5.
Schneider, Bryan P., Sandra K. Althouse, Milan Radovich, et al.. (2023). Clinicogenomic Landscape of Metastatic Thymic Epithelial Tumors. JCO Precision Oncology. 7(7). e2200465–e2200465. 4 indexed citations
6.
7.
Loehrer, Patrick J., et al.. (2023). Understanding the landscape of immunotherapy in thymic epithelial tumors. Cancer. 129(8). 1162–1172. 11 indexed citations
8.
Gralow, Julie R., Fredrick Chite Asirwa, Ami S. Bhatt, et al.. (2020). Recommendations from the ASCO Academic Global Oncology Task Force. JCO Global Oncology. 6(6). 1666–1673. 11 indexed citations
9.
Ermel, Aaron, Ann M. Moormann, Susan Cu‐Uvin, et al.. (2020). Low sensitivity of the careHPV™ Assay for detection of Oncogenic Human Papillomavirus in cervical samples from HIV-infected and HIV-uninfected Kenyan women. eCommons - AKU (Aga Khan University). 4(1). 1–5.
10.
Hellyer, Jessica A., Matthew A. Gubens, Kristen Cunanan, et al.. (2019). Phase II trial of single agent amrubicin in patients with previously treated advanced thymic malignancies. Lung Cancer. 137. 71–75. 11 indexed citations
11.
Rajan, Arun, Chul Kim, Udayan Guha, et al.. (2017). OA18.02 Evaluation of a Modified Dosing Regimen (2-Weeks on/1-Week off) of Sunitinib as Part of a Phase II Trial in Thymic Carcinoma. Journal of Thoracic Oncology. 12(1). S313–S314. 6 indexed citations
12.
Radovich, Milan, Jeffrey P. Solzak, Bradley A. Hancock, et al.. (2016). A large microRNA cluster on chromosome 19 is a transcriptional hallmark of WHO type A and AB thymomas. PMC. 3 indexed citations
13.
Wakelee, Heather A., Sukhmani K. Padda, Matthew Burns, et al.. (2015). Oral 1.01: Phase II trial of amrubicin in patients with previously treated advanced thymic malignancies. Journal of Thoracic Disease. 7(3). 101. 1 indexed citations
14.
Huang, James, Usman Ahmad, Alberto Antonicelli, et al.. (2014). Development of the International Thymic Malignancy Interest Group International Database: An Unprecedented Resource for the Study of a Rare Group of Tumors. Journal of Thoracic Oncology. 9(10). 1573–1578. 73 indexed citations
15.
Gökmen‐Polar, Yesim, et al.. (2013). The role of histology in predicting recurrence of type A thymomas: a clinicopathologic correlation of 23 cases. Modern Pathology. 26(8). 1059–1064. 35 indexed citations
16.
Loehrer, Patrick J., Yang Feng, Higinia R. Cárdenes, et al.. (2011). Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial. Journal of Clinical Oncology. 29(31). 4105–4112. 604 indexed citations breakdown →
17.
18.
Berlin, Jordan, Kathleen J. Propert, Donald L. Trump, et al.. (1998). 5-Fluorouracil and Leucovorin Therapy in Patients With Hormone Refractory Prostate Cancer. American Journal of Clinical Oncology. 21(2). 171–176. 20 indexed citations
19.
Loehrer, Patrick J., Stephen D. Williams, & Lawrence H. Einhorn. (1989). Ifosfamide in testicular cancer: the Indiana University experience.. PubMed. 16(1 Suppl 3). 96–101. 10 indexed citations
20.
Young, Robert C., Joseph V. Simone, Robert F. Ozols, et al.. (1989). The Year book of oncology. Bulletin of Miscellaneous Information (Royal Gardens Kew). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lawrence H. Einhorn Breakdown of academic impact, for papers by Mark Krailo Breakdown of academic impact, for papers by Patrick Schöffski Breakdown of academic impact, for papers by Herbert Chen Breakdown of academic impact, for papers by Hans‐Joachim Schmoll Breakdown of academic impact, for papers by Ian Judson Breakdown of academic impact, for papers by Carsten Bokemeyer Breakdown of academic impact, for papers by Ronald de Wit Breakdown of academic impact, for papers by Andrew K. Stewart Breakdown of academic impact, for papers by Filippo de Braud
Rankless by CCL
2026